Inmed Pharmaceuticals - Common Shares (INM) closed at $13.21 on November 5, 2026, down 24.5% from the previous close, on volume of 32,776 shares (30-day average 61,135).
Data as of November 5, 2026.
No press releases found.
InMed Pharmaceuticals Completes Share Consolidation and Name Change
TipRanks (Thu, 5-Nov 6:38 AM ET)
InMed Advances Mentari Merger Amid Nasdaq Compliance Review
TipRanks (Tue, 3-Nov 9:40 AM ET)
InMed Pharmaceuticals GAAP EPS of -$0.36
Seeking Alpha News (Tue, 3-Nov 7:36 AM ET)
InMed Announces Proposed Ten-for-One Share Consolidation
TipRanks (Mon, 2-Nov 5:53 PM ET)
InMed Announces 1-for-10 Share Consolidation Tied to Proposed Merger
TipRanks (Mon, 2-Nov 4:51 PM ET)
InMed Pharmaceuticals announces 1-for-10 share consolidation
Seeking Alpha News (Mon, 2-Nov 4:41 PM ET)
Mentari’s $200 Million Private Placement and Merger with InMed Signal Ambitious Clinical Push
Market Chameleon (Wed, 22-Jul 5:53 AM ET)
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
Inmed Pharmaceuticals - Common Shares trades on the NASDAQ stock market under the symbol INM.
As of November 5, 2026, INM stock price declined to $13.21 with 32,776 million shares trading.
INM has a beta of 2.10, meaning it tends to be more sensitive to market movements. INM has a correlation of 0.04 to the broad based SPY ETF.
INM has a market cap of $7.26 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, INM traded as high as $156.96 and as low as $5.75.
INM has underperformed the market in the last year with a return of -23.6%, while the SPY ETF gained +9.7%. In the last 3 month period, INM fell short of the market, returning -11.3%, while SPY returned -4.7%. However, in the most recent 2 weeks INM has outperformed the stock market by returning -2.9%, while SPY returned -5.2%.
INM support price is $16.51 and resistance is $18.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INM shares will trade within this expected range on the day.
